搜索临床试验以:Akt 抑制剂 MK2206
总计68213个结果
-
AbbVie (prior sponsor, Abbott)终止
-
AbbVie (prior sponsor, Abbott)完全的原发性腹膜癌 | 输卵管 | 实体瘤(例如乳腺癌、卵巢癌、前列腺癌或胰腺癌)和卵巢癌荷兰
-
Seoul National University HospitalHK inno.N Corporation; Kureha Corporation完全的
-
Region SkaneLund University招聘中
-
Assistance Publique Hopitaux De Marseille尚未招聘
-
Otsuka Pharmaceutical Development & Commercialization...完全的精神错乱 | 抑郁症 | 沮丧 | 情绪障碍 | 抑郁症,主要美国, 法国, 波兰, 加拿大, 斯洛伐克
-
AbbVie (prior sponsor, Abbott)完全的
-
University of OxfordOxford University Hospitals NHS Trust; Oxford Health NHS Foundation Trust完全的
-
National University of SingaporeAgency for Science, Technology and Research; AMILI Pte. Ltd.招聘中
-
Laureate Institute for Brain Research, Inc.National Institute of General Medical Sciences (NIGMS)完全的
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)完全的
-
Masonic Cancer Center, University of MinnesotaUniversity of Minnesota撤销继发性急性髓性白血病 | 骨髓增生异常综合症 | 治疗相关的急性髓性白血病 | 高危急性髓性白血病美国
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.完全的
-
AbbVie (prior sponsor, Abbott)完全的